Company Filing History:
3 out of 5,089 
3 out of 1,744 
3 out of 42 
Years Active: 2009-2017
Title: Wolf Herve Fridman: Innovator in Targeted Molecular Delivery
Introduction
Wolf Herve Fridman is a notable inventor based in Paris, France. He has made significant contributions to the field of molecular targeting, particularly in the development of innovative carriers for therapeutic applications. With a total of three patents to his name, Fridman's work is recognized for its potential impact on medical science.
Latest Patents
Fridman's latest patents include a universal carrier designed for targeting molecules to GB3 receptor-expressing cells. This invention presents a polypeptidic carrier with the formula STxB-Z(n)-Cys, which allows for the direct or indirect targeting of therapeutic molecules to specific cells. This advancement holds promise for enhancing the efficacy of treatments for various diseases.
Career Highlights
Throughout his career, Wolf Herve Fridman has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. His experience in these organizations has contributed to his expertise in research and innovation in the field of molecular biology.
Collaborations
Fridman has collaborated with esteemed colleagues, including Ludger Johannes and Eric Tartour. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in targeted molecular therapies.
Conclusion
Wolf Herve Fridman is a distinguished inventor whose work in targeted molecular delivery is paving the way for advancements in medical treatments. His contributions through patents and collaborations reflect his commitment to innovation in the scientific community.